• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Factors Associated With Receipt of Partial Nephrectomy or Minimally Invasive Surgery for Patients With Clinical T1a and T1b Renal Masses: Implications for Regionalization of Care.与临床 T1a 和 T1b 肾脏肿块患者接受部分肾切除术或微创手术相关的因素:对医疗区域化的影响。
Clin Genitourin Cancer. 2020 Dec;18(6):e643-e650. doi: 10.1016/j.clgc.2020.03.011. Epub 2020 Mar 20.
2
Utilization and quality outcomes of cT1a, cT1b and cT2a partial nephrectomy: analysis of the national cancer database.cT1a、cT1b 和 cT2a 部分肾切除术的利用和质量结果:国家癌症数据库分析。
BJU Int. 2018 Apr;121(4):565-574. doi: 10.1111/bju.14055. Epub 2017 Nov 29.
3
Differential efficacy of ablation therapy versus partial nephrectomy between clinical T1a and T1b renal tumors: A systematic review and meta-analysis.临床 T1a 和 T1b 期肾肿瘤消融治疗与部分肾切除术疗效的差异:系统评价和荟萃分析。
Urol Oncol. 2022 Jul;40(7):315-330. doi: 10.1016/j.urolonc.2022.04.002. Epub 2022 May 11.
4
Partial nephrectomy is not associated with an overall survival advantage over radical nephrectomy in elderly patients with stage Ib-II renal masses: An analysis of the national cancer data base.部分肾切除术与根治性肾切除术相比,在老年 Ib-II 期肾肿块患者中并不具有总体生存优势:国家癌症数据库分析。
Cancer. 2018 Oct 1;124(19):3839-3848. doi: 10.1002/cncr.31582. Epub 2018 Sep 12.
5
Toward greater adoption of minimally invasive and nephron-sparing surgical techniques for renal cell cancer in the United States.在美国,推动肾细胞癌微创和保留肾单位手术技术的更广泛应用。
Urol Oncol. 2016 Oct;34(10):433.e9-433.e17. doi: 10.1016/j.urolonc.2016.05.021. Epub 2016 Jun 16.
6
Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies.部分肾切除术与根治性肾切除术治疗 T1b 和 T2 期临床肾肿瘤的比较:系统评价和荟萃分析。
Eur Urol. 2017 Apr;71(4):606-617. doi: 10.1016/j.eururo.2016.08.060. Epub 2016 Sep 7.
7
Cryoablation versus Partial Nephrectomy for Clinical T1b Renal Tumors: A Matched Group Comparative Analysis.冷冻消融与部分肾切除术治疗 T1b 期临床肾肿瘤:匹配组对比分析。
Eur Urol. 2017 Jan;71(1):111-117. doi: 10.1016/j.eururo.2016.08.039. Epub 2016 Aug 25.
8
A comparison of overall survival and perioperative outcomes between partial and radical nephrectomy for cT1b and cT2 renal cell carcinoma-Analysis of a national cancer registry.cT1b和cT2期肾细胞癌行部分肾切除术与根治性肾切除术的总生存率及围手术期结局比较——一项国家癌症登记分析
Urol Oncol. 2018 Mar;36(3):90.e9-90.e14. doi: 10.1016/j.urolonc.2017.11.008. Epub 2017 Dec 16.
9
Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.部分肾切除术与经皮消融术治疗 cT1 期肾肿瘤的比较。
Eur Urol. 2015 Feb;67(2):252-9. doi: 10.1016/j.eururo.2014.07.021. Epub 2014 Aug 6.
10
Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.cT1 期肾肿瘤行部分肾切除术与经皮消融术后的肿瘤学结局。
Eur Urol. 2019 Aug;76(2):244-251. doi: 10.1016/j.eururo.2019.04.026. Epub 2019 May 3.

引用本文的文献

1
The intersection of travel burdens and financial hardship in cancer care: a scoping review.癌症护理中旅行负担和经济困难的交集:范围综述。
JNCI Cancer Spectr. 2024 Sep 2;8(5). doi: 10.1093/jncics/pkae093.
2
Impacts of Neighborhood Characteristics and Surgical Treatment Disparities on Overall Mortality in Stage I Renal Cell Carcinoma Patients.社区特征和手术治疗差异对Ⅰ期肾细胞癌患者总体死亡率的影响
Int J Environ Res Public Health. 2022 Feb 12;19(4):2050. doi: 10.3390/ijerph19042050.
3
Sex and Gender Differences in Kidney Cancer: Clinical and Experimental Evidence.肾癌中的性别差异:临床与实验证据
Cancers (Basel). 2021 Sep 13;13(18):4588. doi: 10.3390/cancers13184588.
4
Delaying surgery for clinical T1b-T2bN0M0 renal cell carcinoma: Oncologic implications in the COVID-19 era and beyond.在 COVID-19 时代及以后,延迟 T1b-T2bN0M0 期肾细胞癌的手术治疗:肿瘤学意义。
Urol Oncol. 2021 May;39(5):247-257. doi: 10.1016/j.urolonc.2020.10.012. Epub 2020 Oct 20.

本文引用的文献

1
Evolving Trends for Selected Treatments of T1a Renal Cell Carcinoma.T1a 期肾细胞癌治疗方法的演变趋势。
Urology. 2019 Oct;132:136-142. doi: 10.1016/j.urology.2019.06.029. Epub 2019 Jul 4.
2
Centralization of High-Risk Cancer Surgery Within Existing Hospital Systems.高危癌症手术在现有医院系统内的集中化。
J Clin Oncol. 2019 Dec 1;37(34):3234-3242. doi: 10.1200/JCO.18.02035. Epub 2019 Jun 28.
3
National trends and disparities of minimally invasive surgery for localized renal cancer, 2010 to 2015.2010 年至 2015 年局限性肾癌微创外科治疗的国家趋势和差异。
Urol Oncol. 2019 Mar;37(3):182.e17-182.e27. doi: 10.1016/j.urolonc.2018.10.028. Epub 2019 Jan 8.
4
Trends in Renal-Cell Carcinoma Incidence and Mortality in the United States in the Last 2 Decades: A SEER-Based Study.过去 20 年美国肾细胞癌发病率和死亡率的趋势:基于 SEER 的研究。
Clin Genitourin Cancer. 2019 Feb;17(1):46-57.e5. doi: 10.1016/j.clgc.2018.10.002. Epub 2018 Oct 11.
5
The Temporal Association of Robotic Surgical Diffusion with Overtreatment of the Small Renal Mass.机器人手术的普及与小肾肿瘤过度治疗的时间关联。
J Urol. 2018 Nov;200(5):981-988. doi: 10.1016/j.juro.2018.05.081. Epub 2018 May 22.
6
Relationship of surgeon/hospital volume with outcomes in uro-oncology surgery.外科医生/医院手术量与泌尿肿瘤外科学术结果的关系。
Curr Opin Urol. 2018 May;28(3):251-259. doi: 10.1097/MOU.0000000000000490.
7
Trends in Utilization of Robotic and Open Partial Nephrectomy for Management of cT1 Renal Masses.肾部分切除术治疗 cT1 期肾癌:机器人手术与开放手术应用趋势。
Eur Urol Focus. 2019 May;5(3):482-487. doi: 10.1016/j.euf.2017.12.006. Epub 2018 Jan 8.
8
Cancer statistics, 2018.癌症统计数据,2018 年。
CA Cancer J Clin. 2018 Jan;68(1):7-30. doi: 10.3322/caac.21442. Epub 2018 Jan 4.
9
A comparison of overall survival and perioperative outcomes between partial and radical nephrectomy for cT1b and cT2 renal cell carcinoma-Analysis of a national cancer registry.cT1b和cT2期肾细胞癌行部分肾切除术与根治性肾切除术的总生存率及围手术期结局比较——一项国家癌症登记分析
Urol Oncol. 2018 Mar;36(3):90.e9-90.e14. doi: 10.1016/j.urolonc.2017.11.008. Epub 2017 Dec 16.
10
Is the Distance Worth It? Patients With Rectal Cancer Traveling to High-Volume Centers Experience Improved Outcomes.这段距离值得吗?前往高容量中心就医的直肠癌患者预后更佳。
Dis Colon Rectum. 2017 Dec;60(12):1250-1259. doi: 10.1097/DCR.0000000000000924.

与临床 T1a 和 T1b 肾脏肿块患者接受部分肾切除术或微创手术相关的因素:对医疗区域化的影响。

Factors Associated With Receipt of Partial Nephrectomy or Minimally Invasive Surgery for Patients With Clinical T1a and T1b Renal Masses: Implications for Regionalization of Care.

机构信息

Section of Urologic Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ.

Department of Biostatistics and Epidemiology, Rutgers School of Public Health, Piscataway, NJ.

出版信息

Clin Genitourin Cancer. 2020 Dec;18(6):e643-e650. doi: 10.1016/j.clgc.2020.03.011. Epub 2020 Mar 20.

DOI:10.1016/j.clgc.2020.03.011
PMID:32389458
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7502425/
Abstract

PURPOSE

To identify factors associated with receipt of partial nephrectomy (PN) and minimally invasive surgery (MIS) in patients with clinical T1 renal cell carcinoma (RCC) using the National Cancer Data Base (NCDB).

METHODS

We queried the NCDB from 2010 to 2014 identifying patients treated surgically for cT1a-bN0M0 RCC. Logistic regression was used to examine associations between socioeconomic, clinical, and treatment factors, and receipt of MIS or PN within the T1 patient population.

RESULTS

Our cohort included 69,694 patients (cT1a, n = 44,043; cT1b, n = 25,651). For cT1a tumors, 70% of patients received PN and 65% underwent MIS. For cT1b tumors, 32% of patients received PN and 62% underwent MIS. cT1a and cT1b patients with household income < $62,000, without private insurance, and treated outside academic centers were less likely to receive MIS or PN. cT1a patients traveling > 31 miles were more likely to undergo MIS. For both cT1a/b, the farther a patient traveled for treatment, the more likely a PN was performed.

CONCLUSION

Data showed an increase in utilization of MIS and PN from 2010 to 2014. However, patients in the lowest socioeconomic groups were less likely to travel and were more likely to receive more invasive treatments. On the basis of these findings, additional research is needed into how regionalization of RCC surgery affects treatment disparities.

摘要

目的

利用国家癌症数据库(NCDB),确定与临床 T1 期肾细胞癌(RCC)患者接受部分肾切除术(PN)和微创外科手术(MIS)相关的因素。

方法

我们从 2010 年至 2014 年在 NCDB 中查询了接受手术治疗 cT1a-bN0M0 RCC 的患者。使用逻辑回归检查了社会经济、临床和治疗因素与 T1 患者人群中接受 MIS 或 PN 的相关性。

结果

我们的队列包括 69694 名患者(cT1a,n=44043;cT1b,n=25651)。对于 cT1a 肿瘤,70%的患者接受 PN,65%的患者接受 MIS。对于 cT1b 肿瘤,32%的患者接受 PN,62%的患者接受 MIS。家庭收入<62000 美元、没有私人保险且在学术中心以外接受治疗的 cT1a 和 cT1b 患者不太可能接受 MIS 或 PN。cT1a 患者旅行距离超过 31 英里更有可能接受 MIS。对于 cT1a/b 患者,旅行距离越远,接受 PN 的可能性越大。

结论

数据显示,2010 年至 2014 年,MIS 和 PN 的使用率有所增加。然而,社会经济地位最低的患者旅行的可能性较小,更有可能接受侵入性更大的治疗。基于这些发现,需要进一步研究 RCC 手术的区域化如何影响治疗差异。